Inovio Pharmaceuticals Q3 EPS $(0.50) Misses $(0.21) Estimate, Sales $298.901K Miss $3.631M Estimate
Benzinga Newsdesk 11 hours ago
NewsEarningsEarnings Misses
Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.21) by 138.1 percent. This is a 42.53 percent increase over losses of $(0.87) per
Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.21) by 138.1 percent. This is a 42.53 percent increase over losses of $(0.87) per share from the same period last year. The company reported quarterly sales of $298.901 thousand which missed the analyst consensus estimate of $3.631 million by 91.77 percent.